Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

CUSIP: 74365A309

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
80,165,500
Total 13F shares
1,193,025
Share change
+16,795
Total reported value
$1,298,298
Put/Call ratio
16%
Price per share
$1.09
Number of holders
27
Value change
+$25,721
Number of buys
10
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q2 2022

As of 30 Jun 2022, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,193,025 shares. The largest 10 holders included MEITAV DASH INVESTMENTS LTD, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Spire Wealth Management, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., JANE STREET GROUP, LLC, TWO SIGMA ADVISERS, LP, CITADEL ADVISORS LLC, Virtu Financial LLC, and CAPITAL PERFORMANCE ADVISORS LLP. This page lists 27 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.